2025년 최신 피망머니상 시세표 총정리
Magenta Therapeutics was a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplantation to patients with blood cancers, autoimmune diseases, and genetic disorders. Founded in 2016 and headquartered in Cambridge, Massachusetts, the company merged with Dianthus Therapeutics in 2023.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountApr 2018
May 2017
Nov 2016
Create a free account to see which investors have funded this company.
Create Free Account
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotechnology company developing T-cell engager therapeutics for autoimmune and in...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
